Fact CheckerSign in

NCT03519386CompletedPhase 3

Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%

Prospective, Randomized Phase III Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%

Source: ClinicalTrials.gov · Last updated 29 Nov 2024

Brief summary (registry, in English)

Phase III study to compare the safety and efficacy of intraocular implants containing travoprost at two different elution rates versus Timolol Maleate Ophthalmic Solution, 0.5% (timolol) in reducing elevated intraocular pressure in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT).

Status (registry)
Completed
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
590 (actual)
First submitted
26 Apr 2018
Start date
26 Jul 2018
Primary completion date
5 Apr 2022
Lead sponsor
Glaukos Corporation
NCT number
NCT03519386

What you commit to

  • Study type: Interventional · Phase 3
  • Participants enrolled: 590
  • From 26 Jul 2018 to the primary completion date, 5 Apr 2022
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Retinal disorders not associated with glaucoma.

Other

  • Active corneal inflammation or edema.

Who the study is looking for

  • Diagnosed with open-angle glaucoma or ocular hypertension.
  • C/D ratio ≤ 0.8
  • Zero to three preoperative ocular hypotensive medications

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Vance Thompson Vision
Coordinator of this site? Confirm its status
Sioux FallsUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.